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Summary.-Freshly excised human embryonic tissue used as antigen to test lympho-
cytes from a cancer bearing patient gives a " normal tissue " result of about 10%
in the macrophage electrophoresis migration (MEM) test. When, however, it is grown
in vitro and then used as an antigenic stimulant to cancer lymphocytes, a " cancer-
like " result (about 150/) is produced. These new antigenic determinant(s) akin to
those associated with cancer basic protein appear rapidly (within 5-5 hours) in vitro.
Cultures of " normal " cells are thus antigenically different from the same cells in
context in vivo.
DURING the study of HeLa and other
cell lines as a possible source of cancer
basic protein (CaBP) (Field and Caspary,
1970; Caspary and Field, 1971; Dickinson,
Caspary and Field, 1972) WI 38 cells
were unexpectedly found to possess the
antigenic properties of cancer transformed
cells. Since this cell line is generally
regarded as non-transformed, a study was
made of the antigenic properties before
and after various periods in culture of
normal human embryonic tissue with
respect to lymphocytes from cancer
patients. It was found that within a
few hours in vitro a new antigenic deter-
mninant appeared in association with the
cultured cells with the same properties
as CaBP.
MATERIALS AND METHODS
Pieces of lung were removed under sterile
conditions from healthy human embryos
10-16 weeks) obtained fresh at hysterotomy
termination of pregnancy. After washing in
TC 199 part of the lung tissue was imme-
diately cut up with scissors and finely dis-
persed by mincing in a small volume of TC
199. Finally the small pieces were forced
through stainless steel 50 and then 150 mesh
cytosieves. No trypsin wAas used. The
suspension was allowed to sediment for
15-30 min and then used for monolayer
cultures and the supernate for suspension
cultures (see below). A portion of the cell
suspension was snap frozen in liquid nitrogen
before culture to provide control material.
For culture periods longer than 48 hours the
sedimented small pieces of tissue were re-
suspended in 10% foetal calf serum in TC 199
and 5 ml aliquots transferred to 5 cm Esco-
plastic AA grade petri dishes for monolayer
cultures to form. For culture periods shorter
than 48 hours monolayer growth proved
insufficient. Therefore the supernate con-
taining single and small clumps of cells was
washed twice in TC 199, resuspended in 10%
foetal calf serum in TC 199 and grown as sus-
pension cultures with 8 x 106 cells in 1 ml in
7 ml screw-cap bottles. Cultures were incu-
batedat36°Cinagassedhumidifiedincubator.
When necessary the nutrient medium was
changed twice a week. After periods ranging
from 1 to 21 hours with cells in suspension,
and 2-25 days with monolayer cultures, the
cells were snap frozen in liquid nitrogen
-196°C and then stored at -70°C for
subsequent testing. Monolayer cultures when
confluent were removed by first rinsing off
nutrient medium with Dulbecco PBSa and
then dispersing with Versene (0 02%) in
PBSa, aided by mechanical flushing. AgainE. J. FIELD, D. HUGHES AND E. A. CASPARY
no trypsin was used since Dickinson et al.
(1972) had reported that this removes
CaBP antigenic determinants from the
surface of HeLa cells. Suspension cultures
were frozen in the culture bottle without
treatment. When thawed the cells were
washed, resuspended in TC 199 at 106/ml
and homogenized before testing. Cultures
were prepared similarly from brain, thymus,
spleen and kidney tissue.
The presence of CaBP in the various
preparations was tested by the macrophage
electrophoretic migration (MEM) test (Field
and Caspary, 1970, 1971; Caspary and
Field, 1971). Since it is known that lympho-
cytes from patients suffering from malignant
(but not benign) neoplasia respond to CaBP
(Caspary and Field, 1971) andrelatedantigens
(Field and Caspary, 1970; Field, Caspary and
Carnegie, 1971), the various cell preparations
were tested for the presence of antigen which
acte(c like CaBP using lymphocytes from
cancer patients.
In principle, the MEM test depends upon
the observation that sensitized lymphocytes
react with antigen to liberate some material
(involving protein synthesis by the cells
(Caspary, 1971)) with the property of
causing normal guinea-pig macrophages to
travel more slowly in an electric field.
Normal guinea-pig macrophages are thus
used as an indicator system for lymphocyte
antigen interaction in much the same way as
sensitized sheep red cells are used in a
Wassermann reaction. The macrophage
slowing factor (MSF) may be identical with
macrophage migration inhibition factor
(MIF).
Normal guinea-pig macrophages were
raised by intraperitoneal injection of 20 ml
sterile liquid paraffin and washing out with
heparinized Hanks' solution 6-10 days later.
After the cells had been washed and sus-
pended in medium 199 free from heparin they
were subjected to 100 rad y irradiation from
a cobalt bomb toobviate (atleasttemporarily)
their ability to take part in atwo-wayreaction
with human lymphocytes, as explained by
Caspary and Field (1971). A one-way re-
action is compensated for in a control
specimen.
Lymphocytes were obtained from 15 ml
ofvenous blood and separated by the method
of Coulson and Chalmers (1964) as modified
by Hughes and Caspary (1970) using carbonyl
iron and methyl cellulose. The human
embryo cells (HEC) to be used were washed
in medium 199. In carrying out a test 106
HEC were mixed with 106 lymphocytes (it
having already been shown that this number
of HeLa cells could be used as a source of
CaBP antigen for the stimulation ofsensitized
lymphocytes (Dickinson et al., 1972)) and 107
irradiated macrophages in a total volume of
3*0 ml of medium 199 and incubated at 20°C
(room temperature) for 90 min. The control
specimen contained macrophages and human
lymphocytes alone. All measurements were
made " blind " on randomly scrambled
specimens in a Zeiss cytopherometer, 10
macrophages (readily recognized under phase
contrast by their size and content of liquid
paraffin) being timed in each direction of the
potential difference so that a mean of 20
observations could be determined. Full
experimental details with an original protocol
in extenso are given by Caspary and Field
(1971).
If te = time when no antigen is present
tc = time when no antigenis present (control),
then te > t, and (te -t)I(tc) X 100 is a
measure of the slowing produced and hence
of the lymphocyte sensitization to antigen.
These percentage slowing figures are those




derived from a male aged 59 with hyper-
nephroma. With CaBP made from a
carcinoma of cervix (TCC), sensitization
was 14.5%, i.e. in this particular case at
the lower end of the range associated with
malignant disease. With freshly pre-
pared 106 lung cells from human embryo
the result was 9 6%-i.e. the type of
figure expected with normal tissue cells
or with the protein extracted from them
in the same manner as CaBP (Dickinson
et al., 1972) and different from the CaBP
result (P < 0.001). When the same
human embryo lung (HEL) had been in
culture 3, 5 or 6 days the results were
14-2, 14-1 and 14-1 (both at 5 days) and
14-0% respectively. Thus, once the tissue
had been in culture it apparently acted
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with antigenic properties similar to those
of CaBP.
Experiment 2. A similar experiment
extending over a longer period showed that
whilst lymphocytes from a female of 35
years with a carcinoma of breast gave
1490/0 with CaBP (TCC, from carcinoma
of cervix), the fresh HEL gave 10.100
(i.e. the expected normal tissue reaction).
The same tissue after 6, 14 and 25 days
in vitro gave 15 7, 15 1 and 1550%-
results not significantly different from the
original result with CaBP. The CaBP
type of antigenicity had thus been main-
tained in culture for at least 25 days.
Experiment 3.-This experiment was
designed to test the effect of rapid (lethal)
freezing, or of being allowed to stand
overnight at 40(1, on the ability of HEL
cells to provide antigenic stimulation to
cancer lymphocytes. Lymphocytes from
a patient with carcinoma of the prostate
gland were found to give 15.700 when
tested with TCC (CaBP from carcinoma
of cervix). When the HEL cells were
frozen immediately they had been disso-
ciated they gave a normal tissue result of
10-0%. W;hen allowed to stand viable
overnight at 4°C the result was 10.6%
and when an aliquot of such cells was
frozen before being used it was 10.300.
In another experiment, HEL grown for
5 days gave 14.1% with lymphocytes
from a patient with hypernephroma;
with CaBP the result was 14.50/. When
the material was frozen and later retested
with lymphocytes from a patient (aged 67)
with cancer of the breast the result was
15-20°; these lymphocytes gave 15.3%
when tested with CaBP. These experi-
ments showed that killing the cells by
freezing (and thawiing before use) did not
interfere with their antigenic capacity
either when this was done as soon as the
*ells had been dissociated or after they
had been maintained for 18 hours at 40C
or had been cultured at 37°C. Merely
standing 24 hours without active growth
did not lead to the appearance of CaBP
activity. Thelatterisevidently associated
with growth in vitro. All material was
29
thereafter tested afterfreezing as a routine.
Experiment 4.-This experiment was
designed to find out the effect of 5000 rad
ofy-irradiation on the antigenic properties
of HEL cells both fresh and after culture.
Using lymphocytes from a patient with
cancer of the breast, CaBP from cervical
cancer gave 15.30°. Aliquots of HEL
which had been freshly prepared and then
frozen at 20°C for 24 hours gave 9 7,
9.9, 9-7 and 9.90, i.e. the usual normal
tissue values. When such frozen material
was thawed and then subjected to 5000
rad irradiation before being used as test
antigen the result was 10.20o, i.e. un-
altered. Thus irradiation did not affect
the antigenicity ofstarting HEL material.
Culturing at 37°C for 5 days followed by
freezing gave 1 5f20. If this material
was exposed to 5000 rad irradiation the
result was 15.100/. Thus exposure to
5000 rad does not alter the antigenic
power of cultured HEL once it has been
developed.
Experiment 5.-This experiment was
set up to test whether actual growth ofthe
explant was needed in order that CaBP
type antigenic properties should develop
in the HEL cells. HEL frozen immedi-
ately and kept at -20°Cfor 24hoursbefore
being thawed and used as antigen gave
9.9% (i.e. normal type result) with cancer
lymphocytes which gave 15.3% with CaBP
(TCC, from the same carcinoma of cervix).
When an aliquot of the same HEL was
maintained at 4°C for 24 hours before
being killed by freezing and then used it
again gave 9.9%. Thus, maintaining
the HEL under conditions in which there
would be no growth and little metabolism
led to no development of cancer-type
antigenic properties. When, however, anI
aliquot was maintained at 37°C for 24
hours, then killed and tested it gave 14.30(1.
Thus a period of growth of 24 houirs re-
sulted in the emergence of CaBP tYpe of
antigenic capacity.
Experiment 6. This experiment w,,as
designed to determine the length of time
for which HEL must grow in vitro for
the cancer-type antigenic property to
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TABLE I. Rapid Appearance of a Cancer-like Antigen with Time in Cultured
Human Foetal Lung Cell Suspension Culture
Antigen added to 0 5 x 106 lymphocytes
from human carcinoma patient
CaBP (made from human cancer of cervix uteri)
106 human foetal lung cell suspension:
Frozen immediately prepared
30 min in culture at 37 C
1 hour in culture at 37°C
2 hours in culture at 37°C
3 hours in culture at 37 C
4 hours in culture at 37°C
.5-5 hours in culture at 37°C
11 hours in culture at 37°C













* Caleculated thus: if te = mobility in presence of antigen; tc = mobility without anitigen; then te > tc
an(1 (te- t)I(tc) x 100 represents the slowing of macrophage electrophoretic mobility and is a measure of
lymphocyte sensitization (full details Caspary and Field, 1971). Differences > 2 1 ar-e significant at,
P =) 01.
develop. Lymphocytes from a patient
with carcinoma of the bronchus were
found to give 14 6°o with CaBP from cer-
vical cancer. An aliquot of HEL frozen
immediately it was prepared and preserved
at 20°C (which Experiment 3 showed
not to have any effect upon the antigenic
stimulant property of the HEL) gave
9.2% (i.e. the normal tissue result).
Other aliquots were put in culture for
periods of 1, 2, 3, 4, 55, 11 and 21 hours
and then snap frozen. Later they were
tested and the results are shown in Table
I. It can be seen that the normal tissue
response (i.e. about 10%) is preserved
until 4 hours. At 5-5 hours the result
12 5"0 is statistically different from that
at 4 hours and thereafter the figure
becomes the full cancer type result (ca.
14 15 0 ). Thus the cancer-type antigenic
reactivity emerges at about 5 hours and
is maintained thereafter.
Otherfoetal tis8ues
In order to determine whether the
phenomenon described above was limited
to HEL (which seemed unlikely) similar
experiments were set up with brain,
thymus, spleen and kidney of the same
foetuses. Similar emergence of antigenic
activity corresponding with that of CaBP
was observed in all cases. The results
with these other tissues together with all
those with HEL are presented in Table II.
DISCUSSION
All the human embryonic tissue tested
before culture (lung, brain, spleen, thymus
and kidney) when used as antigen, either
fresh or after deep freezing, to stimulate
lymphocytes from patients with different
cancers, gave an MEM test slowing of
about 1000, i.e. the normal tissue type
response obtained with extracts of adult
normal tissue prepared in the same way as
CaBP is prepared from malignant tissue.
When, however, these tissues were culti-
vated in vitro they developed antigenic
determinant(s) that elicited a response
equivalent to that obtained with CaBP,
i.e. 14-15%/ slowing. The emergence of
cancer-type antigenic determinant(s)
occurred within 6 hours and was fully
developed by 11 hours. It is clear that
foetal tissue freed from the subtle restric-
tive limitations imposed upon it by its
biological context rapidly takes on newr
antigenic properties. Alterations in cell
antigenicity in culture has been described
in other instances: loss of HL-A antigens
in fibroblasts paralleling senescence (Sas-
portes, Dehay and Fellows, 1971), changes
in blood group H antigen in HeLa cells
(Pann and Kuhns, 1972), loss or masking
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Period of Macrophage electrophoretic mobility
culture slowing*
deys (d) % % %
1 9-2 15-2 14-6
2 9 7 14-7 15-3
2 9 9 15-3 15-3
3 9-5 14-2 14-5
.z 10-0 14-1 14-5
5 10-0 14-1 14-5
6 9-6 14-0 14-5
6 9-7 15-7 14 9
14 10*1 15*1 14*9







* See Table I.
t Antigen added to 0 5 x 106 lymphocytes from
of surface antigens in clonal rat glial cell
line C6 (Pfeiffer et al., 1971). Such
changes are often in response to an altered
environment. However, the changes re-
ported here relate to the rapid appearance
of antigenic determinants possibly closely
related to those derived from tumour
tissue. It is suggestive in view of the
short time needed for these to develop
that the changes may be associated with
the onset of mitotic division and this
could be tested. It has been reported
that mouse non-tumorigenic cell lines
become tumour producing within 30
generations if culture techniques are
arranged to select those cells that are
insensitive to contact inhibition of cell
division (Aaronson and Todaro, 1968).
The tumorigenicity of cells possessing
the CaBP-like antigenic determinant des-
cribed in this report has not been investi-
gated, but is unlikely.
Attention was drawntothisunexpected
behaviour of normal embryonic tissue
in vitro by the equally unforeseen finding
that WI 38 cells-a human embryo lung
cell line usually regarded as non-malignant
-were just as effective as HeLa cells (a






.4 -7 14-7 14-7
human carcinoma patient.
transformed line) in reacting with lympho-
cytes from cancer patients. However,
preliminary titration studies using basic
protein acid extracts (unpublished) have
indicated that while the equivalent of the
standard antigen dose of 106 short-term
cultured cells gives a similar response to
the WI 38 and HeLa cells, the relative
amounts of reacting antigen are consider-
ably greater in the established cell lines.
The exquisite sensitivity of the MEM test
may be detecting new antigenic deter-
minants related to active cell division
present in varying amounts in the briefly
cultured foetal lung, in established cell
lines, as well as in in vivo tumours-all
capable of eliciting a response from
lymphocytes from carcinoma patients.
Alternatively, these new antigenic deter-
minants may be cross reacting with anti-
gens specific to cancers or could indeed
be closely related, if not identical, to
CaBP. Although the location of the new
CaBP-like determinant(s) is not known
it is reasonable to suppose that, as in the
case offrankly malignant cells, it is on the
surface plasmalemmal membrane and not
associated with endoplasmic reticulum
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or the nucleus (Dickinson et al., 1972).
The location and density of concanalin A
binding sites when cells are grown in vivo
have also been associated with acquisition
of malignancy in hamster polyoma, SV 40
or DMNA transformed cells (Inbar, Ben-
Bas.at and Sachs, 1972).
The special antigenic reactivity of
cells maintained in vitro will need to be
taken into account in the interpretation
of experiments designed to induce sensi-
tization against " normal " cells in vitro.
Such cells, even after brief periods of
culture, are no longer equivalent to the
cells of the intact animals since they now
possess new antigens (closely akin if not-
identical to antigens extractable from
tumour tissue and able to activatelympho-
cytes from carcinoma patients) not present
in the normal cells. In the light of these
findings attempts to produce " auto-
immunity " in vitro call for careful inter-
pretation. Thus Cohen, Globerson and
Feldman (1971) reported that in vitro
interaction of rat or mouse lymphoid
cells with syngeneic fibroblasts appeared
to induce an immunospecific response.
In seeking to explain their results they
write " It may be claimed that syngeneic
fibroblasts contained 'foreign' antigens,
. . . due to in vitro modifications of the
cells . . ." and claim that " circumstantial
evidence " argues against this. However,
it is precisely this development of new or
" foreign " antigens in vitro which has
been observed in the present work.
Whilst further study of the nature of
the CaBP-like antigenic material which
appears in vitro is continuing, it is already
clear that in all properties so far tested
(e.g. resistance to irradiation, to trypsin,
extractability by acid, blockage by anti ,u
chain serum, inactivation by trypan blue
or DNA, etc.) a remarkable coincidence
with CaBP extracted from human tumours
is apparent (Field, Hughes and Caspary,
in preparation). The balance between
two types ofchromosomes has been shown
to control the expression or suppression
ofmalignant cell transformation (Hitotsu-
machi, Rabinowitz and Sachs, 1971).
The relationship between such genetic
changes and the nature of the " loss
of context" stimulus associated with
the transformation is fundamental and
enigmatic with obvious importance for
the evolution of " cancerous change ".
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